Table 2.
Signal strength of AEs related to HPIs at the system organ class (SOC) level. Signal strength was categorized based on the lower bound of the ROR 95% confidence interval (ROR05): ++ (strong): ROR05 > 2; + (potential): ROR05 > 1; - (no signal): ROR05 ≤ 1. ROR, reporting odds ratio; CI, confidence interval.
| Sonidegib | Vismodegib | |||||
|---|---|---|---|---|---|---|
| SOC | Reports | ROR (95% CI) | Signal Strength | Reports | ROR (95% CI) | Signal Strength |
| Surgical and medical procedures | 115 | 3.43 (2.84, 4.14) | ++ | 121 | 0.43 (0.36, 0.51) | - |
| Musculoskeletal and connective tissue disorders | 264 | 2.24 (1.97, 2.55) | + | 2771 | 2.84 (2.73, 2.96) | ++ |
| Metabolism and nutrition disorders | 95 | 1.97 (1.60, 2.41) | + | 1024 | 2.52 (2.36, 2.68) | ++ |
| Gastrointestinal disorders | 259 | 1.32 (1.16, 1.50) | + | 2556 | 1.56 (1.50, 1.63) | + |
| Investigations | 179 | 1.29 (1.11, 1.50) | + | 1360 | 1.17 (1.10, 1.23) | + |
| renal and urinary disorders | 60 | 1.28(0.99, 1.65) | + | 160 | 0.42(0.36, 0.49) | - |
| cardiac disorders | 58 | 1.16(0.9, 1.51) | + | 194 | 0.4(0.35, 0.47) | - |
| Neoplasms benign, malignant and unspecified | 67 | 1.08 (0.85, 1.38) | + | 381 | 0.79 (0.71, 0.87) | - |
| Nervous system disorders | 190 | 0.99 (0.86, 1.15) | - | 2853 | 1.85 (1.78, 1.93) | + |
| General disorders and administration site conditions | 383 | 0.86 (0.77, 0.96) | - | 3206 | 0.86 (0.83, 0.89) | - |
| Skin and subcutaneous tissue disorders | 117 | 0.84 (0.70, 1.01) | - | 1941 | 1.81 (1.73, 1.90) | + |
| ear and labyrinth disorders | 6 | 0.56(0.25, 1.26) | - | 88 | 1.01(0.82, 1.24) | + |
| hepatobiliary disorders | 7 | 0.35(0.17, 0.73) | - | 186 | 1.08(0.94, 1.25) | + |
| Other SOCs with weaker or no signals | - | - | ||||